ramucirumab + nab-paclitaxel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ramucirumab + nab-paclitaxel, covering 2020-11-19 to 2020-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]